Quetiapine Tablet, Film Coated
Product Images NDC 71205-026

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 71205-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Fumarate Structural Formula (378c155e 34bc 4167 9fc3 A4b6a7465414 01)

Quetiapine Fumarate Structural Formula (378c155e 34bc 4167 9fc3 A4b6a7465414 01)
Chemical structure diagram showing the molecular composition of Quetiapine, with a portion indicating a carboxylate group. This image represents the active ingredient Quetiapine, used in the film-coated tablet dosage form.*
FDA Label Image

Figure 1 (378c155e 34bc 4167 9fc3 A4b6a7465414 02)

Figure 1 (378c155e 34bc 4167 9fc3 A4b6a7465414 02)
A line graph depicting the proportion of patients with relapse (%) over time (weeks) for two groups: QTP+LIVAL (dashed line) and PLA+LIVAL (solid line). The x-axis represents time in weeks up to 100 weeks, and the y-axis shows the percentage of patients with relapse from 0 to 100%. The PLA+LIVAL group shows a higher proportion of relapse compared to the QTP+LIVAL group throughout the period.*
FDA Label Image

Figure 2 (378c155e 34bc 4167 9fc3 A4b6a7465414 03)

Figure 2 (378c155e 34bc 4167 9fc3 A4b6a7465414 03)
A line graph showing the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two groups are compared: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The PLA+LI/VAL group shows a higher and steeper increase in relapse proportion compared to the QTP+LI/VAL group.*
FDA Label Image

71205-026-90 (Image 05)

71205-026-90 (Image 05)
Label for Quetiapine 300 mg tablets, film-coated, oral dosage form, containing 90 tablets per bottle. The label identifies the product as prescription-only, manufactured by TEVA Czech Industries in the Czech Republic and packaged by Proficient Rx LP in Thousand Oaks, CA. It includes medication guide instructions and storage conditions at 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.